XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 67 filers reported holding XENON PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,202 | +74.2% | 35,210 | +96.2% | 0.01% | +100.0% |
Q2 2023 | $690 | -99.9% | 17,946 | +12.7% | 0.01% | 0.0% |
Q3 2022 | $574,000 | -5.1% | 15,927 | -20.0% | 0.01% | -14.3% |
Q2 2022 | $605,000 | +282.9% | 19,902 | +92.2% | 0.01% | +600.0% |
Q3 2021 | $158,000 | -54.5% | 10,357 | -44.5% | 0.00% | -66.7% |
Q2 2021 | $347,000 | -7.0% | 18,654 | -10.7% | 0.00% | -25.0% |
Q1 2021 | $373,000 | +56.7% | 20,878 | +14.6% | 0.00% | -60.0% |
Q4 2019 | $238,000 | – | 18,220 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |